Hip Arthroscopy Postoperative Opioid Demands
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorRush University Medical Center
About this trial
This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.
Eligibility criteria
Qualifiers
Adult patients age 18-80 years
English speaking
Opioid naive patient (defined as not taking opioid pills within 6 weeks prior to surgery), confirmed by checking the Illinois Prescription monitoring program
Primary hip arthroscopy
Disqualifiers
Minors (<18 years of age)
Opioid tolerant patients
Revision surgery
Prior infections of the operative joint
Trial design
Treatments tested in this trial
- Control Group Regimen
- Opioid reduced regimen
Treatment groups
170 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov